Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

OTLC Financial Statements and Analysis

PNK : OTLC

Oncotelic Therapeutics, Inc.

$0.04
0-
At Close 4:00 PM

OTLC FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

OTLC Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue000070.00K
cost of revenue00000
gross profit000070.00K
gross profit ratio00001.00
research and development expenses480.00252.00480.0010.995K21.221K
general and administrative expenses80.277K96.33K166.742K102.468K34.301K
selling and marketing expenses00000
selling general and administrative expenses80.277K96.33K166.742K102.468K34.301K
other expenses3.20M012.538K00
operating expenses3.281M96.582K167.222K113.463K55.522K
cost and expenses3.281M96.582K167.222K113.463K55.522K
interest income00000
interest expense205.616K215.619K234.709K207.686K185.424K
depreciation and amortization114.722K34.03K167.222K3.21K3.21K
ebitda-3.166M-62.552K-167.22K-113.46K14.478K
ebitda ratio00000.207
operating income-3.281M-96.582K-167.22K-113.46K14.478K
operating income ratio00000.207
total other income expenses net-90.894K-181.591K-307.953K-677.612K212.007K
income before tax-3.372M-278.173K-475.175K-791.072K41.061K
income before tax ratio00000.587
income tax expense00-66.499K-55.089K-74.248K
net income-3.304M-209.837K-408.676K-735.983K115.309K
net income ratio00001.647
eps-0.008-0.001-0.001-0.0020.00
eps diluted-0.008-0.001-0.001-0.0020.00
weighted average shs out407.29M401.596M399.379M399.184M397.777M
weighted average shs out dil407.29M401.596M399.379M399.184M397.777M
Graph

OTLC Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents149.018K72.216K208.989K190.405K268.022K
short term investments00000
cash and short term investments149.018K72.216K208.989K190.405K268.022K
net receivables18.976K18.976K18.976K18.976K18.976K
inventory000020.00K
other current assets71.036K100.766K3.23K62.356K58.546K
total current assets239.03K191.958K231.195K271.737K365.544K
property plant equipment net00000
goodwill2.788M5.988M5.988M5.988M5.988M
intangible assets01.102M1.102M01.102M
goodwill and intangible assets2.788M7.09M7.09M5.988M7.09M
long term investments22.653M22.653M22.653M22.653M22.641M
tax assets00000
other non current assets1.102M001.102M0
total non current assets26.543M29.743M29.743M29.743M29.731M
other assets00000
total assets26.782M29.935M29.974M30.015M30.096M
account payables1.692M1.686M1.653M2.001M1.668M
short term debt10.642M10.773M10.681M11.099M11.484M
tax payables00000
deferred revenue00-1.0001.116M
other current liabilities4.023M3.745M4.178M3.406M2.844M
total current liabilities16.357M16.204M16.512M16.505M17.111M
long term debt2.293M2.227M2.213M1.898M899.099K
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities000-1.000
total non current liabilities2.293M2.227M2.213M1.898M899.099K
other liabilities001.001.000
capital lease obligations00000
total liabilities18.65M18.432M18.725M18.403M18.011M
preferred stock001.0000
common stock4.073M4.073M3.997M3.992M3.982M
retained earnings-37.44M-34.135M-33.925M-33.517M-32.781M
accumulated other comprehensive income loss00000
other total stockholders equity42.219M42.219M41.763M41.655M41.348M
total stockholders equity8.853M12.157M11.834M12.13M12.549M
total equity8.132M11.504M11.249M11.612M12.086M
total liabilities and stockholders equity26.782M29.935M29.974M30.015M30.096M
minority interest-720.592K-653.427K-585.091K-518.592K-463.503K
total investments22.653M22.653M22.653M22.653M22.641M
total debt12.935M13.001M13.315M12.997M12.383M
net debt12.786M12.531M13.106M12.807M12.115M
Graph

OTLC Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateMar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
deferred income tax00000
stock based compensation00000
change in working capital119.968K-354.157K173.878K-74.745K168.697K
accounts receivables00000
inventory00000
accounts payables101.234K-353.533K175.646K-17.301K149.253K
other working capital18.734K-624.00-1.768K-57.444K19.444K
other non cash items-43.942K717.523K-463.789K6.476M19.896K
net cash provided by operating activities-231.416K-372.617K-248.85K-448.563K-251.017K
investments in property plant and equipment00000
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites00000
debt repayment-250.00K-435.00K-335.00K-440.00K-200.00K
common stock issued00000
common stock repurchased0-125.00K-50.00K00
dividends paid00000
other financing activites250.00K-35.00K720.00K880.00K400.00K
net cash used provided by financing activities250.00K275.00K335.00K440.00K200.00K
effect of forex changes on cash00000
net change in cash18.584K-97.617K86.15K-8.563K-51.017K
cash at end of period208.989K190.405K288.022K201.872K210.435K
cash at beginning of period190.405K288.022K201.872K210.435K261.452K
operating cashflow-231.416K-372.617K-248.85K-448.563K-251.017K
capital expenditure00000
free cash flow-231.416K-372.617K-248.85K-448.563K-251.017K
Graph

Frequently Asked Questions

How did Oncotelic Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, OTLC generated $0.00 in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did Oncotelic Therapeutics, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Oncotelic Therapeutics, Inc. reported a $0.00 Gross Profit for the quarter ended Mar 31, 2024.
Have OTLC's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. OTLC incurred $3.28M worth of Operating Expenses, while it generated -$3.28M worth of Operating Income.
How much Net Income has OTLC posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Oncotelic Therapeutics, Inc., the company generated -$3.30M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Oncotelic Therapeutics, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Oncotelic Therapeutics, Inc. as of the end of the last quarter was $149.02K.
What are OTLC's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, OTLC had Total Net Receivables of $18.98K.
In terms of Total Assets and Current Assets, where did Oncotelic Therapeutics, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of OTLC were $239.03K, while the Total Assets stand at $26.78M.
As of the last quarter, how much Total Debt did Oncotelic Therapeutics, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of OTLC's debt was $12.94M at the end of the last quarter.
What were OTLC's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, OTLC reported total liabilities of $18.65M.
How much did OTLC's Working Capital change over the last quarter?
Working Capital Change for OTLC was $119.97K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
OTLC generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. OTLC generated -$231.42K of Cash from Operating Activities during its recently reported quarter.
What was OTLC's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. OTLC reported a $18.58K Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph